Table 2.
Gene | Protein change | Nat | Patient/family | Age (years) | Onset (years) | Frequency (per year) | Duration (days) | Face | Extremities | Abdominal | Upper airways | Genitalia |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ACE | p.G354R | B | 1/17 | 49 | 16 | 12 | 3 | – | × | – | × | – |
B | 2/17 | 25 | NI | < 1 | < 1 | – | – | × | – | – | ||
D | 1/14 | 54 | 10 | 4 | 3 | × | × | × | × | × | ||
p.Y244C | D | 6/1 | 73 | 15 | < 1 | 2–3 | × | × | × | – | – | |
B | 1/24 | 42 | 7 | 2 | 3 | × | × | × | × | × | ||
p.T916M | D | 3/1 | 71 | 21 | 3 | 2–3 | × | × | × | – | – | |
D | 7/1 | 36 | 10 | 18 | 3 | × | × | × | × | – | ||
NOS3 | p.D287N | D | 5/1 | 16 | 3 | 2 | NI | – | – | × | – | – |
KLKB1 | p.C548Y | D | 3/1 | 71 | 21 | 3 | 2–3 | × | × | × | – | – |
D | 6/1 | 73 | 15 | < 1 | 2–3 | × | × | × | – | – | ||
B | 4/27 | 51 | Asympt. | Asympt. | Asympt. | Asympt. | Asympt. | Asympt. | Asympt. | Asympt. |
The mutations were analyzed as probably pathogenic when classified as damaging for all the in silico software assessed (SIFT, PolyPhen-2, PROVEAN, and CADD). Asympt, asymptomatic; NI, not identified.